Skip to main content
. 2025 May 8;78(2):192–198. doi: 10.5173/ceju.2024.0212

Table 1.

Patient demographic and surgical characteristics

Sample (n = 125) Group SJ (n = 60) Group DJ (n = 65) p
Demographic characteristics
Sex, n (%)
 Male 70.0 (56.0%) 31.0 (51.7%) 39 (60.0%) 0.35
Age (years), M ±SD 57.2 ±12.2 56.8 ±12.0 57.5 ±12.4 0.60
BMI (kg/m2), Mdn (IQR) 27.4 (24.8–31.2) 26.4 (24.5–30.1) 27.8 (25.0–32.4) 0.10
Comorbidities
Previous urolithiasis, n (%) 86.0 (68.8%) 44.0 (73.3%) 42.0 (64.6%) 0.29
Previous urolithiasis surgery, n (%) 80.0 (64.0%) 40.0 (66.7%) 40.0 (61.5%) 0.55
Arterial Hypertension, n (%) 52.0 (41.6%) 26.0 (43.3%) 26.0 (40.0%) 0.71
Diabetes mellitus, n (%) 25.0 (20.0%) 10.0 (16.7%) 15.0 (23.1%) 0.37
Depression, n (%) 16.0 (12.8%) 9.0 (15.0%) 7 (10.8%) 0.48
ASA Score, n (%)
 ASA I 13 (10.4%) 6 (10.0%) 7 (10.8%) 0.97
 ASA II 90 (72.0%) 43 (71.7%) 47 (72.3%)
 ASA III 22 (17.6%) 11 (18.3%) 11 (16.9%)
Lithiasis and surgery data
Side, n (%)
 Left 72 (57.6) 39 (65.0) 33 (50.8) 0.11
Stone number, n (%)
 One 87 (69.6) 36 (60.0) 51 (78.5) 0.03
 Multiple 38 (30.4) 24 (40.0) 14 (21.9)
Stone maximum diameter (mm), Mdn (IQR) 11.0 (9.0–14.0) 10.0 (9.0–13.0) 12.0 (9.0–15.0) 0.06
Stone density (HU), Mdn (IQR) 980.0 (525.0 –1343.3) 1,060.0 (525.0 – 1363.0) 900.0 (500.0 –1341.0) 0.63
Pre-stenting – ureteral stent in place at the time of surgery, n (%) 54 (43.2) 26 (43.3) 28 (43.1) 0.98
Surgery duration (min), Mdn (IQR) 27.0 (20.5–34.5) 27.0 (21.0–34.0) 27.0 (20.0–36.0) 0.84

ASA – American Society of Anesthesiologists; HU – Hounsfield units; IQR – interquartile range; M – Mean; Mdn – Median; SD – standard deviation